Iqvia Holdings Inc.
IQVQ2 2024(IQV Q1 FY2024)Estimated3.5% AI
AI Revenue %
3.5%
AI Fair Value
$670.0M
AI Revenue (Q)
$130.8M
Total Revenue (Q)
$3.7B
Source: SEC EDGAR 10-Q Filing
View 10-Q on SEC.govAnalysis
No AI revenue breakout. TAS segment was $1,453M (38.9% of $3,737M total). IQVIA increasingly emphasized 'Healthcare-grade AI' in 2024, suggesting deeper AI integration. Increasing AI penetration estimate to ~9% of TAS = ~$131M, or ~3.5% of total revenue.
Analyzed by claude-opus-4-6
Quoted Figures
Technology & Analytics Solutions revenues $1,453M; Total revenues $3,737M for Q1 2024
10-Q filed 2024-03-31, Segment Data
AI Products Identified (Ring 1)
IQVIA Connected IntelligenceHealthcare-grade AI platformAnalytics-driven clinical developmentAI-powered real world evidence
AI-Enabled Items (Ring 2 — Not Counted)
These items use AI but are not counted in the AI revenue estimate because they primarily serve non-AI functions.
Traditional data subscriptionsLegacy analytics platformsClinical research services (non-AI)Contract sales services
Confidence Tier
EstimatedNo direct AI revenue disclosure — estimated from product mix